Avanos Medical Stock Beta
8HH Stock | 14.40 0.40 2.70% |
Avanos Medical fundamentals help investors to digest information that contributes to Avanos Medical's financial success or failures. It also enables traders to predict the movement of Avanos Stock. The fundamental analysis module provides a way to measure Avanos Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avanos Medical stock.
Avanos |
Avanos Medical Company Beta Analysis
Avanos Medical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Competition |
In accordance with the recently published financial statements, Avanos Medical has a Beta of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Beta (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
All Next | Launch Module |
Avanos Fundamentals
Current Valuation | 1.35 B | |||
Price To Book | 0.97 X | |||
Price To Sales | 1.60 X | |||
Revenue | 820 M | |||
EBITDA | 122.9 M | |||
Net Income | 50.5 M | |||
Total Debt | 226.3 M | |||
Cash Flow From Operations | 90.9 M | |||
Market Capitalization | 1.26 B | |||
Total Asset | 1.79 B | |||
Z Score | 3.0 | |||
Net Asset | 1.79 B |
About Avanos Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avanos Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avanos Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avanos Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.